The State Drug Administration held a meeting on the operation of the "Clean Source" drug management action to consolidate and enhance the work.

On December 10, the National Medical Products Administration held a national drug operation "Clean Source" consolidation and improvement work meeting in Fuzhou. Since the beginning of this year, drug regulatory authorities across the country have focused on the compliance of channels, the legality of products, and the traceability of processes, deepening the "Clean Source" operation. The effectiveness of drug information traceability application has gradually become apparent, and the level of standardization in online and offline sales continues to improve. A total of 32,000 cases of illegal and irregularities have been investigated and dealt with, and the operation has achieved phased results. The meeting emphasized the need for all regions to further expand the results of the "Clean Source" operation, continuously cultivate high-quality business entities, innovate drug network sales supervision mechanisms, empower daily supervision with technology, coordinate and strengthen the investigation and handling of cases, and continuously improve business supervision capabilities.